SENSEX NIFTY

Kiran Mazumdar Shaw

Aug 18, 2014 at 09:02 | Source: CNBC-TV18
Kiran Mazumdar-Shaw goes back the memory lane and shares her life journey with Vijay Amritraj.
Aug 07, 2014 at 10:51 | Source: CNBC-TV18
The healthcare major remains committed to listing Syngene with an increase in Research and Development (R&D) spends, says Kiran Mazumdar Shaw, CMD, Biocon.
Jul 28, 2014 at 22:02 | Source: CNBC-TV18
CII National Committee on Biotechnology Chairperson and Biocon CMD Kiran Mazumdar Shaw has written an open letter to the Prime Minister, seeking his intervention over "unilateral fixing" of drug prices by NPPA .
Jul 28, 2014 at 20:46 | Source: PTI
In an open letter to PM, CII National Committee on Biotechnology Chairperson Kiran Mazumdar Shaw said the "unilateral fixing" of drug prices by NPPA based on "an inequitable formula" has done collateral damage to indigenous industry.
Jul 25, 2014 at 11:53 | Source: CNBC-TV18
According to the management, the flagship biopharma business of the company, which contributes close to 75 percent of the revenues, was impacted this quarter due to geopolitical tensions in Middle East.
Jul 16, 2014 at 18:25 | Source: CNBC-TV18
CNBC-TV18's Shereen Bhan spoke to Kiran Mazumdar Shaw, CMD of Biocon and CM Gulati is Editor, Monthly Index of Medical Specialities (MIMS) to get their perspective on how the governments new move is likely to impact the pharma industry.
Jul 10, 2014 at 22:18 | Source: CNBC-TV18
In an interview to CNBC-TV18s Shereen Bhan, Adi Godrej, Kiran Mazumdar Shaw, Ajay Shriram, Naina Lal Kidwai, Jayant Sinha and Madhu Kela discuss their take on Arun Jaitelys maiden Union Budget and their outlook on the road ahead for the Modi government.
Jul 09, 2014 at 12:56 | Source: CNBC-TV18
The countdown to the 'Modi' Budget is on its last leg. What is India Inc expecting from finance minister Arun Jaitley? Watch Kiran Mazumdar-Shaw, CMD of Biocon talk to Anuj Singhal and Ekta Batra of CNBC-TV18 about that.
Jun 12, 2014 at 16:45 | Source: CNBC-TV18
Vishal Sikka was earlier on the executive board of SAP AG and will be taking over from SD Shibulal said it was humbling to be selected to lead the IT behemoth.
Jun 06, 2014 at 20:02 | Source: CNBC-TV18
In terms of top honchos, Sunil Mittal, Shashi Ruia, Kiran Mazumdar-Shaw were present and so were the heads of CII, FICCI and ASSOCHAM.
Messages on Kiran Mazumdar Shaw »

stocktin

Platinum Member

51 Followers

Biocon  

which involves big bucks like the 2g,3g, coal etc.In the similar context industrialists like KMS are flower pots they r the face of Indian industry after all you cant showcase an ex custom house clearing agent like Gautam Adani to the world as the face of Indian Industry for that you need Kiran Mazumdar

6.31 PM Jun 9th

Web Messenger

Platinum Member

234421 Followers

News Now  

Source:VC Circle - The company expects its small molecule API and ANDA business to be lead revenue generator followed by research services, biosimilars and branded formulations. Biocon Ltd is India's largest biotechnology company founded by Kiran Mazumdar-Shaw in ...

2.34 PM May 7th

sanecounsel

Platinum Member

74 Followers

Biocon  

BANGALORE: Kiran Mazumdar-Shaw on Friday for the very first time used the words `succession planning`, after having built Biocon into a Rs 3,000-crore global biopharmaceutical enterprise and making it the poster child of India`s biotech prowess in a span of over three decades. The board of Biocon

11.32 AM Apr 27th

stocktin

Platinum Member

51 Followers

Biocon  

ramanujam11 : Great post & the comparision with Apple .however , I am a little queasy about your first point regarding the ipo ,statin company & the hype.Who benefited from the hype created at the time of ipo?? And if this is true then everything that Biocon and Kiran Mazumdar Shaw stand for can

11.29 AM Mar 15th

Web Messenger

Platinum Member

234421 Followers

News Now  

Source:The Hindu BusinessLine - Indian Institute of Management-Bangalore (IIM-B) has appointed Kiran Mazumdar-Shaw as the Chairperson of its board of governors. At the meeting of the board of governors on February 11, the Chairperson, Mukesh D. Ambani, expressed his decision to step down, IIM

4.35 PM Feb 19th

srikanth031
086

Gold Member

44 Followers

Biocon  

Kiran Mazumdar-Shaw, chairman and managing director of Indian biopharmaceutical company Biocon Ltd., will receive the 2014 Othmer Gold Medal at the Chemical Heritage Foundation’s 13th annual Heritage Day celebration May 15. CHF president and CEO Carsten Reinhardt said in a statement that Mazumdar

2.16 PM Jan 31st

Web Messenger

Platinum Member

234421 Followers

Biocon  

Source:Economic Times - MUMBAI: Biocon has justified the Rs 19,500-57,500 pricing for its new breast cancer drug Canmab , with the company`s chairman and managing director Kiran Mazumdar-Shaw saying that the first biosimilar version of Swiss drug maker Roche`s offering has expanded the market.

12.04 PM Jan 25th

Firstpost

Platinum Member

882 Followers

Economy  

Source:FirstPost - Even though several corporate India executives have recently joined the Aam Aadmi Party while others like Bicon`s Kiran Mazumdar shaw have praised the party for itsanti-corruption stand and, the party` s populist measures are worrying investors on Dalal Street.At the heart

1.15 PM Jan 6th

Web Messenger

Platinum Member

234421 Followers

Biocon  

Source:The Hindu BusinessLine - Rakesh Bamzai, President-Marketing, Biocon Ltd, is leaving the company to take up leadership role elsewhere. He has been associated with Biocon for 19 years.Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon, said that Rakesh has decided to take up

7.08 PM Jan 2nd

Web Messenger

Platinum Member

234421 Followers

Biocon  

Source:The Hindu BusinessLine - Rakesh Bamzai, President-Marketing, Biocon Ltd, is leaving the company to take up leadership role elsewhere. He has been associated with Biocon for 19 years.Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon, said that Rakesh has decided to take up

1.04 PM Jan 2nd

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.